Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 6, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Discovery of new prodrugs by new 3D culture platform assures treatment of Type 1 diabetes

Life Sciences Drug Discovery Project Recruitment at JNU

The Significant Impact of the New Normal on rural communities

Discovery of new prodrugs by new 3D culture platform assures treatment of Type 1 diabetes
  • BiotechToday
  • World

Discovery of new prodrugs by new 3D culture platform assures treatment of Type 1 diabetes

bioxone December 21, 2020December 21, 2020

Devyani Goswami, Amity University Kolkata

The individuals having Type 1 diabetes have a loss of β cells. They are unable to synthesize insulin properly; insulin injections and pluripotent stem cell-derived β cells (SC β cells) have clothed to be promising treatment but not as effective as there remain certain drawbacks. The 2D cell cultures lack support in vivo conditions while 3D cell cultures are expensive. Resolving this problem, the researchers developed Disque Platform (DP), in which stem cell-derived β cells are aggregated into thin, 3D discs within 2D 96-well plates. 

Β cells have high zinc concentration compared to other cells. Using this idea the researchers discovered a brand new zinc-binding prodrug (ZnPD), which establishes a release control based on the chelation of zinc ions. It provides a way for the specific delivery of drugs to β cells. Since 2D and 3D cell cultures have drawbacks, the invention of the Disque Platform for correct functioning and screening of this new prodrug has to take place. This new technique was checked against both the 2D and 3D cell culture systems, after which the Disque Platform was subjected to the events of ZnPDs supported harmine, which is capable of inducing human β cell proliferation. 

The Disque Platform mimics the 2D and 3D culture very well; the experimenting and screening techniques were rapid and efficient. The harmine based ZnPD is more efficient than the earlier harmine treatment.

Although, further studies and researches are required to scale back the seedling size of the Disque platform so that the general price might be reduced. Overall, this method assures to be a discovery and could be utilized in experimental fields.

Also read: Human Gene in Fruit Fly Helps in MGS Study

REFERENCE: 1) New screening platform leads to discovery of next generation prodrugs for type 1 diabetes

https://medicalxpress.com/news/2020-12-screening-platform-discovery-next-generation-prodrugs.html

2) A 3D culture platform enables development of zinc binding prodrugs for targeted proliferation of β cells

https://advances.sciencemag.org/content/6/47/eabc3207

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged 2D cell cultures 3D cell cultures Disque Platform (DP) type 1 diabetes Zinc (II) ions zinc-binding prodrug (ZnPD) β-cells

One thought on “Discovery of new prodrugs by new 3D culture platform assures treatment of Type 1 diabetes”

  1. Pingback: The Significant Impact of the New Normal on rural communities - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

The Significant Impact of the New Normal on rural communities

bioxone December 21, 2020

Sampriti Roy, University of Calcutta Along with masks and online meetings, what has been unanimous for all age groups and professions since the beginning of the pandemic or the new normal is ‘struggle.’ The mental and physical struggles in this pandemic have been one of a kind and massive in proportions. But one of the […]

rural communities

Related Post

  • BiotechToday
  • World

Mitochondrial DNA Develops Resistance in Animals against Climate Change

BioTech Today July 23, 2021July 22, 2021

Agrima Bhatt, Rajasthan University The continuous changes in climate conditions are happening at a very rapid pace due to global warming. We are already observing the effects of climate change whether it is the heat waves in Canada or the recent flooding in Germany. The predicted results of the past are quickly coming true. Although […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • FEATURED
  • India
  • Latest
  • World

COVID UPDATE: AstraZeneca’s Covid-19 vaccine trials to be resumed again

bioxone September 12, 2020September 12, 2020

-Anuska Sen, Team bioXone On 10th September 2020, that is 2 days back, Team BioXone had covered a piece of news stating the pause of the Covid-19 vaccine of AstraZeneca by Serum Institute. Today, it has been reported that once again, the trials for AstraZeneca’s Covid-19 vaccine has been successfully resumed. The one reason that […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Transcriptomic analysis of etiology behind fatality in HIV patients

BioTech Today June 22, 2021June 21, 2021

Kanikah Mehndiratta Transcriptomic analysis has been a recent approach to identify biomarkers associated with normal or diseased physiology in patients. An obvious approach to targeting any infection or disease through treatment strategies or prophylaxis requires a proper understanding of the mechanisms of its pathogenesis. Researching on better and more effective treatment approaches towards a deadly […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy